Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pixantrone (BBR 2778) in BSHAP Regimen for Relapsed Aggressive NHL
NCT00069966Phase 2Unknown
- Sponsor
- Theradex Oncology
- Start
- Apr 2003
- Modality
- DNA Intercalators/Alkylators
- Countries
- 2
01
Overview
A Phase 2 trial of pixantrone in non-Hodgkin lymphoma (NHL), sponsored by Theradex Oncology. Status: unknown.
02
Drugs
pixantrone
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00069966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00069966.